Associate Director, Global Patient Safety - Ophthalmology
Regeneron is hiring for Associate Director, Global Patient Safety - Ophthalmology in Dublin. Hybrid, Executive level, €104k–€169k a year stated. First seen November 7, 2026; open as of November 13, 2026. Jobs taken straight from company career pages — no aggregator in between.
With Destava: How well do you fit? · Tailor my résumé · Write a cover letter
- Company
- Regeneron
- Where
- Dublin
- Arrangement
- Hybrid
- Level
- Executive
- Pay stated
- €104k–€169k a year
- First seen
- November 7, 2026
- Listed via
- Workday
What the posting says
This position offers the opportunity to contribute to a fast-growing, science-driven organization making a meaningful difference to patients worldwide. When & where: - Work Location: Dublin, IRE - 3 days per week on site - 25% Travel may be required Discover your role: - Complete signal detection activities in line with approved safety surveillance plan - Perform signal evaluation for any identified signals and author the safety evaluation reports - Manage preparation and review of safety documents including DSUR, PSUR, RMP, response to health authority or other queries - Prepare and deliver…
Read more and apply on Regeneron's site
More jobs like this
Senior Manager, GMR Operations CoE - Global Medical Information, Medical Review and Content Creation (GMIMRCC) Operations
Save to applySenior Director Global Patient Safety
Save to applyMedical Devices Manager
Save to applyAssistant Clinic Manager - Tallaght
Save to apply
See all 9 Medical and Health Services Managers jobs in Dublin
A search agent finds the jobs this list misses: the ones that mean the same without the same words. Have Destava watch for associate director, global patient safety - ophthalmology jobs in Dublin, new matches every morning on your own account.
This page includes information from the O*NET 31.0 Database by the U.S. Department of Labor, Employment and Training Administration (USDOL/ETA). Used under the CC BY 4.0 license. O*NET® is a trademark of USDOL/ETA.